Insights Into Tick-Borne Diseases: a Study From an Endemic Area of Northern Italy

NARecruitingINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Tick-Borne Diseases
Interventions
DIAGNOSTIC_TEST

IgG and IgM search for specific Tick-Borne Patogens

"Ticks will be classified based on morphological characteristics by microscopy observation.~For TBP detection by molecular test, Nucleic acid extraction will be performed on ticks lysate or blood using kits MagMAX TM Viral/Pathogen Nucleic Acid Isolation Kit (Thermo Fisher Scientific) on MagEX STARlet platform from Hamilton. Species identification by molecular method will be performed by Sanger sequencing for Rickettsiae and Babesia, and Multi-Locus Sequence Typing will be used to characterize Borrelia.~Serum samples collected throughout the study will be tested to assess any seroconversions during the follow-up period.~Samples will be tested for the presence of specific IgG and IgM for the following TBPs: TBEV, R. typhi. R. conorii, Borrelia spp, Anaplasma, Ehrlichia and Babesia."

Trial Locations (1)

37024

RECRUITING

IRCCS Sacro Cuore Don Calabria hospital, Negrar

All Listed Sponsors
lead

IRCCS Sacro Cuore Don Calabria di Negrar

OTHER